|Peak incidence of pheochromocytoma and primary hyperparathyroidism in multiple endocrine neoplasia 2: need for age-adjusted biochemical screening.|
|PMID: 23284010 Owner: NLM Status: MEDLINE|
|CONTEXT: In multiple endocrine neoplasia type 2, American Thyroid Association (ATA) management guidelines recommend continuous biochemical screening for pheochromocytoma and/or primary hyperparathyroidism. This implicit assumption of linear tumor development is difficult to reconcile with current thinking that cells accrue somatic mutations stochastically, yielding a bell-shaped distribution.
OBJECTIVE: This investigation aimed at evaluating the age distribution of pheochromocytoma and primary hyperparathyroidism in gene carriers at risk of developing multiple endocrine neoplasia type 2.
DESIGN: ATA class D, C, B, and A mutations, with or without pheochromocytoma and/or primary hyperparathyroidism, were plotted against carrier age at the time of diagnosis or last follow-up.
SETTING: The setting was a surgical referral center.
PATIENTS: Included were 474 carriers of ATA class D (37 patients), C (170 patients), B (112 patients), and A (155 patients) mutations. Eighty-four carriers (17.8%) developed pheochromocytoma (bilateral in 42 patients) and 20 carriers (4.2%) primary hyperparathyroidism.
INTERVENTIONS: INTERVENTIONS were adrenalectomy and/or parathyroidectomy.
MAIN OUTCOME MEASURES: Main outcome measures were multiple endocrine neoplasia type 2-associated tumors.
RESULTS: Bell-shaped age distribution curves were obtained for unilateral and bilateral pheochromocytoma (ATA class D, C, and B) and primary hyperparathyroidism (ATA class C and B). Owing to the rarity of events, the bell shape of the distribution curve was faint but consistent with a random distribution for ATA class A mutations (unilateral pheochromocytoma and primary hyperparathyroidism). With decreasing penetrance, the bell-shaped distribution curve, becoming narrower and flatter, shifted to the right toward higher age groups.
CONCLUSIONS: These data, revealing phases of greater amidst phases of lower penetrance, support adjustment of biochemical screening to carrier age and ATA class.
|Andreas Machens; Kerstin Lorenz; Henning Dralle|
|Type: Journal Article Date: 2013-01-02|
|Title: The Journal of clinical endocrinology and metabolism Volume: 98 ISSN: 1945-7197 ISO Abbreviation: J. Clin. Endocrinol. Metab. Publication Date: 2013 Feb|
|Created Date: 2013-02-07 Completed Date: 2013-04-10 Revised Date: 2014-07-31|
Medline Journal Info:
|Nlm Unique ID: 0375362 Medline TA: J Clin Endocrinol Metab Country: United States|
|Languages: eng Pagination: E336-45 Citation Subset: AIM; IM|
|APA/MLA Format Download EndNote Download BibTex|
Adrenal Gland Neoplasms / genetics*, pathology, surgery
Aged, 80 and over
Hyperparathyroidism, Primary / genetics*, pathology, surgery
Multiple Endocrine Neoplasia Type 2a / genetics*, pathology, surgery
Pheochromocytoma / genetics*, pathology, surgery
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Tenascin-X haploinsufficiency associated with Ehlers-Danlos syndrome in patients with congenital adr...
Next Document: Serum visfatin is differentially regulated by insulin and free Fatty acids in healthy men.